pentoxifylline has been researched along with Hepatitis in 5 studies
Hepatitis: INFLAMMATION of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"Feeding mice a methionine choline deficient (MCD) diet serves as a nutritional model of non-alcoholic steatohepatitis (NASH)." | 7.72 | Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. ( Green, RM; Koppe, SW; Malladi, P; Sahai, A; Whitington, PF, 2004) |
"5 times) were given pentoxyfylline at a dosage of 400 mg t." | 6.73 | Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. ( Malhotra, V; Sakhuja, P; Sarin, SK; Satapathy, SK; Sharma, BC, 2007) |
"The evaluation of the efficacy of ursodeoxycholic acid (UDCA), pentoxifylline, losartan, and atorvastatin in non-alcoholic steatohepatitis (NASH) treatment." | 5.12 | Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. ( Georgescu, EF; Georgescu, M, 2007) |
"Feeding mice a methionine choline deficient (MCD) diet serves as a nutritional model of non-alcoholic steatohepatitis (NASH)." | 3.72 | Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. ( Green, RM; Koppe, SW; Malladi, P; Sahai, A; Whitington, PF, 2004) |
"5 times) were given pentoxyfylline at a dosage of 400 mg t." | 2.73 | Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. ( Malhotra, V; Sakhuja, P; Sarin, SK; Satapathy, SK; Sharma, BC, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koppe, SW | 1 |
Sahai, A | 1 |
Malladi, P | 1 |
Whitington, PF | 1 |
Green, RM | 1 |
Georgescu, EF | 1 |
Georgescu, M | 1 |
Chitturi, S | 1 |
Farrell, GC | 1 |
Satapathy, SK | 1 |
Sakhuja, P | 1 |
Malhotra, V | 1 |
Sharma, BC | 1 |
Sarin, SK | 1 |
Koppenhagen, K | 1 |
Wenig, HG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)[NCT04193982] | Phase 3 | 250 participants (Anticipated) | Interventional | 2021-01-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 trials available for pentoxifylline and Hepatitis
Article | Year |
---|---|
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics; | 2007 |
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
Topics: Administration, Oral; Adult; Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Female; | 2007 |
[The effect of pentoxifylline on liver perfusion: a comparative study in patients with liver diseases and in normal subjects, using 198Au-colloid-scintigraphy (author's transl)].
Topics: Adult; Aged; Chronic Disease; Female; Hepatitis; Humans; Liver; Liver Circulation; Liver Cirrhosis; | 1979 |
2 other studies available for pentoxifylline and Hepatitis
Article | Year |
---|---|
Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Topics: Alanine Transaminase; Animals; Choline Deficiency; Deficiency Diseases; Diet; Disease Progression; F | 2004 |
TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
Topics: Animals; Fatty Liver; Hepatitis; Humans; Liver; Liver Cirrhosis; Necrosis; Pentoxifylline; Protectiv | 2007 |